FDANonrulemakingFDA-2016-D-1233
Who commented on this docket
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability
16 organizations filed 16 public comments on Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 3582d ago.
Organizations
16
Comments
16
RIN
—
Comment window
closed 3582d ago
Commenters (16)
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
- American Association for Cancer Researchtrade assoc.1 filing · confidence 85%
- American Association for Clinical Chemistrytrade assoc.1 filing · confidence 85%
- American Cancer Society Cancer Action Networktrade assoc.1 filing · confidence 85%
- American Clinical Laboratory Associationtrade assoc.1 filing · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Medical Informatics Associationtrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Human Geneticstrade assoc.1 filing · confidence 85%
- Association for Molecular Pathologytrade assoc.1 filing · confidence 85%
- Foundation Medicinetrade assoc.1 filing · confidence 85%
- Global Alliance for Genomics and Healthtrade assoc.1 filing · confidence 85%
- National Society of Genetic Counselorstrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Coalition for 21st Century Medicinetrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.